Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic features of Annexin A2 expression in prostate cancer.
Tan SH, Young D, Chen Y, Kuo HC, Srinivasan A, Dobi A, Petrovics G, Cullen J, Mcleod DG, Rosner IL, Srivastava S, Sesterhenn IA. Tan SH, et al. Among authors: sesterhenn ia. Pathology. 2021 Feb;53(2):205-213. doi: 10.1016/j.pathol.2020.07.006. Epub 2020 Sep 20. Pathology. 2021. PMID: 32967771 Free PMC article.
Anterior tumors of the prostate: clinicopathological features and outcomes.
Mygatt J, Sesterhenn I, Rosner I, Chen Y, Cullen J, Morris-Gore T, Barton J, Dobi A, Srivastava S, McLeod D, Brassell SA. Mygatt J, et al. Prostate Cancer Prostatic Dis. 2014 Mar;17(1):75-80. doi: 10.1038/pcan.2013.54. Epub 2013 Dec 3. Prostate Cancer Prostatic Dis. 2014. PMID: 24296774
Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer.
Furusato B, Gao CL, Ravindranath L, Chen Y, Cullen J, McLeod DG, Dobi A, Srivastava S, Petrovics G, Sesterhenn IA. Furusato B, et al. Among authors: sesterhenn ia. Mod Pathol. 2008 Feb;21(2):67-75. doi: 10.1038/modpathol.3800981. Epub 2007 Dec 7. Mod Pathol. 2008. PMID: 18065961 Free article.
ERG oncogene modulates prostaglandin signaling in prostate cancer cells.
Mohamed AA, Tan SH, Sun C, Shaheduzzaman S, Hu Y, Petrovics G, Chen Y, Sesterhenn IA, Li H, Sreenath T, McLeod DG, Dobi A, Srivastava S. Mohamed AA, et al. Among authors: sesterhenn ia. Cancer Biol Ther. 2011 Feb 15;11(4):410-7. doi: 10.4161/cbt.11.4.14180. Epub 2011 Feb 15. Cancer Biol Ther. 2011. PMID: 21178489 Free PMC article.
Clinical potential of the ERG oncoprotein in prostate cancer.
Rosen P, Sesterhenn IA, Brassell SA, McLeod DG, Srivastava S, Dobi A. Rosen P, et al. Among authors: sesterhenn ia. Nat Rev Urol. 2012 Feb 14;9(3):131-7. doi: 10.1038/nrurol.2012.10. Nat Rev Urol. 2012. PMID: 22331093 Review.
Evaluation of ERG responsive proteome in prostate cancer.
Tan SH, Furusato B, Fang X, He F, Mohamed AA, Griner NB, Sood K, Saxena S, Katta S, Young D, Chen Y, Sreenath T, Petrovics G, Dobi A, McLeod DG, Sesterhenn IA, Saxena S, Srivastava S. Tan SH, et al. Among authors: sesterhenn ia. Prostate. 2014 Jan;74(1):70-89. doi: 10.1002/pros.22731. Epub 2013 Sep 21. Prostate. 2014. PMID: 24115221 Free PMC article.
231 results